Bacteriostatic versus bactericidal antibiotics in the treatment of gram-positive endophthalmitis:: Intravitreal erythromycin and vancomycin in experimental S.aureus endophthalmitis.

被引:0
|
作者
Engelbert, M
Callegan, M
Booth, M
Gilmore, MS
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Dean A McGee Eye Inst, Oklahoma City, OK USA
[2] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK USA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
1867B113
引用
收藏
页码:S355 / S355
页数:1
相关论文
共 9 条
  • [1] Intravitreal vancomycin and amikacin versus intravenous imipenem in the treatment of experimental Staphylococcus aureus endophthalmitis
    Engelbert, M
    de Kaspar, HM
    Thiel, M
    Grasbon, T
    Ta, CN
    Schulze-Schwering, M
    Klauss, V
    Kampik, A
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2004, 242 (04) : 313 - 320
  • [2] Intravitreal vancomycin and amikacin versus intravenous imipenem in the treatment of experimental Staphylococcus aureus endophthalmitis
    Michael Engelbert
    Herminia Miño de Kaspar
    Martin Thiel
    Thomas Grasbon
    Christopher N. Ta
    Markus Schulze-Schwering
    Volker Klauss
    Anselm Kampik
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2004, 242 : 313 - 320
  • [3] Comparison of intravenous and intravitreal treatment in experimental S-aureus endophthalmitis: intravitreal amikacin and vancomycin versus intravenous imipenem and a combination of both
    Engelbert, M
    de Kaspar, HM
    Schwering, MS
    Thiel, M
    Klauss, V
    Kampik, A
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S117 - S117
  • [4] Vancomycin-resistant Gram-positive bacterial endophthalmitis: Epidemiology, treatment options, and outcomes
    Khera M.
    Pathengay A.
    Jindal A.
    Jalali S.
    Mathai A.
    Pappuru R.R.
    Relhan N.
    Das T.
    Sharma S.
    Flynn Jr. H.W.
    Journal of Ophthalmic Inflammation and Infection, 3 (1) : 1 - 4
  • [5] Clinical relevance of bacteriostatic versus bactericidal activity in the treatment of gram-positive bacterial infections
    Rhee, KY
    Gardiner, DF
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (05) : 755 - 755
  • [6] Endophthalmitis caused by Gram-positive organisms with reduced vancomycin susceptibility: literature review and options for treatment
    Relhan, Nidhi
    Albini, Thomas A.
    Pathengay, Avinash
    Kuriyan, Ajay E.
    Miller, Darlene
    Flynn, Harry W.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2016, 100 (04) : 446 - 452
  • [7] Effect of intravitreal dexamethasone in combination with vancomycin and amikacin in treatment of Staphylococcus aureus induced experimental endophthalmitis
    Mette, M
    de Kaspar, HM
    Engelbert, M
    Hoepfner, A
    Klauss, V
    Kampik, A
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S5 - S5
  • [8] Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of gram-positive bacterial infections
    Pankey, GA
    Sabath, LD
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (06) : 864 - 870
  • [9] Efficacy and safety of novel glycopeptides versus vancomycin for the treatment of gram-positive bacterial infections including methicillin resistant Staphylococcus aureus: A systematic review and meta-analysis
    Jame, Wissal
    Basgut, Bilgen
    Abdi, Abdikarim
    PLOS ONE, 2021, 16 (11):